139 related articles for article (PubMed ID: 22344882)
1. Multimodal liposomes for SPECT/MR imaging as a tool for in situ relaxivity measurements.
de Vries A; Kok MB; Sanders HM; Nicolay K; Strijkers GJ; Grüll H
Contrast Media Mol Imaging; 2012; 7(1):68-75. PubMed ID: 22344882
[TBL] [Abstract][Full Text] [Related]
2. Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery.
Langereis S; Geelen T; Grüll H; Strijkers GJ; Nicolay K
NMR Biomed; 2013 Jul; 26(7):728-44. PubMed ID: 23703874
[TBL] [Abstract][Full Text] [Related]
3. Quantitative (1)H MRI, (19)F MRI, and (19)F MRS of cell-internalized perfluorocarbon paramagnetic nanoparticles.
Kok MB; de Vries A; Abdurrachim D; Prompers JJ; Grüll H; Nicolay K; Strijkers GJ
Contrast Media Mol Imaging; 2011; 6(1):19-27. PubMed ID: 20648660
[TBL] [Abstract][Full Text] [Related]
4. Relaxivity of liposomal paramagnetic MRI contrast agents.
Strijkers GJ; Mulder WJ; van Heeswijk RB; Frederik PM; Bomans P; Magusin PC; Nicolay K
MAGMA; 2005 Sep; 18(4):186-92. PubMed ID: 16155762
[TBL] [Abstract][Full Text] [Related]
5. Lanthanide-loaded liposomes for multimodality imaging and therapy.
Zielhuis SW; Seppenwoolde JH; Mateus VA; Bakker CJ; Krijger GC; Storm G; Zonnenberg BA; van het Schip AD; Koning GA; Nijsen JF
Cancer Biother Radiopharm; 2006 Oct; 21(5):520-7. PubMed ID: 17105424
[TBL] [Abstract][Full Text] [Related]
6. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
[TBL] [Abstract][Full Text] [Related]
7. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imaging.
Mitchell N; Kalber TL; Cooper MS; Sunassee K; Chalker SL; Shaw KP; Ordidge KL; Badar A; Janes SM; Blower PJ; Lythgoe MF; Hailes HC; Tabor AB
Biomaterials; 2013 Jan; 34(4):1179-92. PubMed ID: 23131536
[TBL] [Abstract][Full Text] [Related]
9. A liposomal MRI contrast agent: phosphatidylethanolamine-DTPA.
Grant CW; Karlik S; Florio E
Magn Reson Med; 1989 Aug; 11(2):236-43. PubMed ID: 2779414
[TBL] [Abstract][Full Text] [Related]
10. A temperature-sensitive liposomal 1H CEST and 19F contrast agent for MR image-guided drug delivery.
Langereis S; Keupp J; van Velthoven JL; de Roos IH; Burdinski D; Pikkemaat JA; Grüll H
J Am Chem Soc; 2009 Feb; 131(4):1380-1. PubMed ID: 19173663
[TBL] [Abstract][Full Text] [Related]
11. Morphology, binding behavior and MR-properties of paramagnetic collagen-binding liposomes.
Sanders HM; Strijkers GJ; Mulder WJ; Huinink HP; Erich SJ; Adan OC; Sommerdijk NA; Merkx M; Nicolay K
Contrast Media Mol Imaging; 2009; 4(2):81-8. PubMed ID: 19191276
[TBL] [Abstract][Full Text] [Related]
12. Dual-targeting of αvβ3 and galectin-1 improves the specificity of paramagnetic/fluorescent liposomes to tumor endothelium in vivo.
Kluza E; Jacobs I; Hectors SJ; Mayo KH; Griffioen AW; Strijkers GJ; Nicolay K
J Control Release; 2012 Mar; 158(2):207-14. PubMed ID: 22079810
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of heterodimer radionuclide nanoparticles for magnetic resonance and single-photon emission computed tomography dual-modality imaging.
Zhu J; Zhang B; Tian J; Wang J; Chong Y; Wang X; Deng Y; Tang M; Li Y; Ge C; Pan Y; Gu H
Nanoscale; 2015 Feb; 7(8):3392-5. PubMed ID: 25584713
[TBL] [Abstract][Full Text] [Related]
14. Targeting of ICAM-1 on vascular endothelium under static and shear stress conditions using a liposomal Gd-based MRI contrast agent.
Paulis LE; Jacobs I; van den Akker NM; Geelen T; Molin DG; Starmans LW; Nicolay K; Strijkers GJ
J Nanobiotechnology; 2012 Jun; 10():25. PubMed ID: 22716048
[TBL] [Abstract][Full Text] [Related]
15. Multimodal contrast agent for combined computed tomography and magnetic resonance imaging applications.
Zheng J; Perkins G; Kirilova A; Allen C; Jaffray DA
Invest Radiol; 2006 Mar; 41(3):339-48. PubMed ID: 16481918
[TBL] [Abstract][Full Text] [Related]
16. Development of a novel lipidic nanoparticle probe using liposomal encapsulated Gd₂O₃-DEG for molecular MRI.
Zohdiaghdam R; Riyahi-Alam N; Moghimi HR; Haghgoo S; Alinaghi A; Azizian G; Ghanaati H; Gorji E; Rafiei B
J Microencapsul; 2013; 30(7):613-23. PubMed ID: 23915304
[TBL] [Abstract][Full Text] [Related]
17. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging.
Mulder WJ; Strijkers GJ; van Tilborg GA; Griffioen AW; Nicolay K
NMR Biomed; 2006 Feb; 19(1):142-64. PubMed ID: 16450332
[TBL] [Abstract][Full Text] [Related]
18. A high relaxivity Gd(III)DOTA-DSPE-based liposomal contrast agent for magnetic resonance imaging.
Hak S; Sanders HM; Agrawal P; Langereis S; Grüll H; Keizer HM; Arena F; Terreno E; Strijkers GJ; Nicolay K
Eur J Pharm Biopharm; 2009 Jun; 72(2):397-404. PubMed ID: 18940253
[TBL] [Abstract][Full Text] [Related]
19. Supramolecular protamine/Gd-loaded liposomes adducts as relaxometric protease responsive probes.
Figueiredo S; Moreira JN; Geraldes CF; Aime S; Terreno E
Bioorg Med Chem; 2011 Feb; 19(3):1131-5. PubMed ID: 20719523
[TBL] [Abstract][Full Text] [Related]
20. MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle.
Mulder WJ; Strijkers GJ; Habets JW; Bleeker EJ; van der Schaft DW; Storm G; Koning GA; Griffioen AW; Nicolay K
FASEB J; 2005 Dec; 19(14):2008-10. PubMed ID: 16204353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
